Supriya Lifescience Ltd Share Price (SUPRIYA)
Check the latest share price of Supriya Lifescience Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 03:16PM, 06 Jun 2025
NSE
Supriya Lifescience Ltd Stock Performance
Get live Supriya Lifescience Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹688.1Day's Price Range₹699.852 Week's Low
52 Week's High
₹33052-Week Price Range₹842
| Returns % | |
| 1 Month Return | + 10.82 % |
| 3 Month Return | + 10.59 % |
| 1 Year Return | + 95.75 % |
| 3 Year Return | + 91.69 % |
| 5 Year Return | + 77.74 % |
| Market Stats | |
| Previous Close | ₹694.70 |
| Open | ₹690.75 |
| Volume | 1.93L |
| Upper Circuit | ₹833.60 |
| Lower Circuit | ₹555.80 |
Supriya Lifescience Ltd Fundamentals & Key Indicators
Check Supriya Lifescience Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹5,591.14 Cr
Return on Equity (ROE)
15.73
PE Ratio (TTM)
0Return on capital employed (ROCE)
22.05
Beta (LTM)
1.84
P/B Ratio
3.27
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
36.42
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
How to invest in Supriya Lifescience Ltd?
Investing in Supriya Lifescience Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Supriya Lifescience Ltd or SUPRIYA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Supriya Lifescience Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Supriya Lifescience Ltd with just a few clicks!
Supriya Lifescience Ltd Stock's Interest Amongst Investors
Supriya Lifescience Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Supriya Lifescience Ltd.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Supriya Lifescience Ltd. Average target price of ₹740
Source: S&P Global Market Intelligence
Supriya Lifescience Ltd Share Price Target
Get share price movements and forecasts by analysts on Supriya Lifescience Ltd.
Supriya Lifescience Ltd price forecast by 1 analysts
Upside of6.52%
High
₹740
Target
₹740.00
Low
₹740
Supriya Lifescience Ltd target price ₹740, a slight upside of 6.52% compared to current price of ₹689.9. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Supriya Lifescience Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Supriya Lifescience Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Supriya Lifescience Ltd Financial Results
Get the annual and quarterly financial summary of Supriya Lifescience Ltd, including revenue, profit, loss and more.
Indices Featuring Supriya Lifescience Ltd Stock
Check stock indices that include Supriya Lifescience Ltd.
Supriya Lifescience Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Supriya Lifescience Ltd.
Supriya Lifescience Ltd Earnings Results
Supriya Lifescience Ltd’s net profit jumped 36.42% since last year same period to ₹50.38Cr in the Q4 2024-2025. On a quarterly growth basis, Supriya Lifescience Ltd has generated 7.7% jump in its net profits since last 3-months.
Read More about Earnings ResultsSupriya Lifescience Ltd Dividends May,2024
In the quarter ending March 2024, Supriya Lifescience Ltd has declared dividend of ₹0.80 - translating a dividend yield of 0.12%.
Read More about Dividends
Supriya Lifescience Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Supriya Lifescience Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.3% | 0.00 | |
| Foreign Institutions | 7.19% | 0.00 | |
| Mutual Funds | 0.66% | 0.00 | |
| Retail Investors | 20.26% | 0.00 | |
| Others | 3.6% | 0.00 |
Supriya Lifescience Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Supriya Lifescience Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 5,591.14 | 15.55% | 0.50 | NA | NA | |
| NA | 418.43 | 116.33% | 0.69 | NA | NA | |
| BUY | 14,219.87 | -4.66% | 0.52 | NA | NA | |
| NA | 9,260.80 | 6.31% | 0.53 | NA | NA | |
| NA | 34.07 | 13.33% | 0.54 | NA | NA |
Supriya Lifescience Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Supriya Lifescience Ltd.
Supriya Lifescience Maintains BUY Rating with Target Price - 03 Jun, 2025
Supriya Lifescience reported a 16.4% YoY revenue increase, with EBITDA and PAT exceeding estimates. Analysts revised EPS estimates upward, maintaining a BUY rating with a target price of INR 843.Supriya Lifescience Projects Strong Revenue Growth - 28 May, 2025
Supriya Lifescience anticipates over 20% annual revenue growth, driven by new product launches and a strong operational performance. Q4FY25 revenue rose 16.4%, with profit after tax up 36.4%. The company expects margins to stabilize between 33% and 35%. A new 10-year API supply contract is projected to add ₹60-70 crore annually at peak. The focus remains on expanding its anaesthetic and specialty therapies portfolio.
Insights on Supriya Lifescience Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, SUPRIYA stock has moved up by 95.8%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 6.52% to 7.19% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.9% return, outperforming this stock by 34.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.30% of holdings in Mar 2025 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 20.26% of holdings in Mar 2025 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 0.67% to 0.66% in Mar 2025 quarter
About Supriya Lifescience Ltd
Revenue: ₹184.11Cr as on March 2025 (Q4 FY25)
Net Profit: ₹50.38Cr as on March 2025 (Q4 FY25)
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
| Organisation | Supriya Lifescience Ltd |
| Industry | Pharmaceuticals |
| CEO | Satish Waman Wagh |
| E-voting on shares | Click here to vote |
Mutual Funds that own Supriya Lifescience Ltd
Check out the Mutual Funds with significant holdings in Supriya Lifescience Ltd.
FAQs
What is Supriya Lifescience Ltd share price today?
Supriya Lifescience Ltd share price today stands at ₹689.9, Open: ₹690.75, Previous Close: ₹694.7, High: ₹699.8, Low: ₹688.1, 52 Week High: ₹842, 52 Week Low: ₹330.
What is today's traded volume of Supriya Lifescience Ltd?
Today's traded volume of Supriya Lifescience Ltd is 1.93L. Which means that 1.93L shares of Supriya Lifescience Ltd were bought and sold on the stock market during today's trading session.
What is Supriya Lifescience Ltd's market cap today?
Today's market capitalisation of Supriya Lifescience Ltd is ₹5,591.14 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Supriya Lifescience Ltd?
Supriya Lifescience Ltd’s 52 week high is ₹842 and 52 week low is ₹330. The current share price of Supriya Lifescience Ltd is ₹689.9, which is -18.06% down from its 52 week high and 109.06% up from its 52 week low.